Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 815-816

  Onody, C ^a   Matsiota Bernard, P ^a   Nauciel, C ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; LEGIONELLA PNEUMOPHILA; MICROBIAL SENSITIVITY TESTS; RIFAMPIN;

EID: 0030738990     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.815     Document Type: Article

References (10)

1. Marrie, T. J. (1993). Community-acquired Legionnaires' disease: a reassessment. In Legionella: Current Status and Emerging Perspectives (Barbaree, J. M., Breiman, R. F. & Dufour, A. P., Eds), pp. 46-7. American Society for Microbiology, Washington, DC.
2. Skoyberg, K., Ruutu, P., Koivula, I., Jousimies-Somer, H. & Valtonen, V. (1994). Effect of immunosuppressive therapy on the clinical presentation of legionellosis. European Journal of Clinical Microbiology & Infectious Diseases 13, 535-41.
3. Edelstein, P. H. & Edelstein, M. A. C. (1989). WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages. Antimicrobial Agents and Chemotherapy 33, 2132-6.
4. Saito, A., Sawatari, K., Fukuda, Y., Nagasawa, M., Koga, H., Tomonaga, A. et al. (1985). Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumoniae in guinea pigs. Antimicrobial Agents and Chemotherapy 28, 15-20.
5. Edelstein, P. H. (1991). Rifampicin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires' disease: study of rifampicin resistance using a guinea pig model of Legionnaires' disease. Antimicrobial Agents and Chemotherapy 35, 5-9.
6. Dowling, J. N., McDevitt, D. A. & Pasculle, A. W. (1985). Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila. Antimicrobial Agents and Chemotherapy 27, 272-4.
7. Moffie, B. G. & Mouton, R. P. (1988). Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics. Journal of Antimicrobial Chemotherapy 22, 457-62.
8. Liebers, D. M., Balten, A. L., Smith, R. P., Hammer, M. C. & Conroy, J. V. (1989). Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. Journal of Antimicrobial Chemotherapy 23, 37-41.
9. Bornstein, N., Roudier, C. & Fleurette, J. (1985). Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media. Journal of Antimicrobial Chemotherapy 15, 17-22.
10. Nauciel, C., Guilhin, P., Matsiota-Bernard, P. & Ronco, E. (1996). Legionellose en région Parisienne: épidémiologie et mortalité. A propos d'une série de 81 cas à culture positive. Presse Médicale , in press.